Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Clinical trial NCT00958841 · TERMINATED

Trial details

NCT number: NCT00958841
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasm Pituitary Neoplasm Nelson Syndrome Ectopic ACTH Syndrome

Start date: 2009-09-01
Primary completion: 2015-06-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.